The deca peptide (BI-10) derived from FSH-BI and conjugated with near-infrared fluorescence dye was investigated and shown to bind to ovarian cancer cells in vivo with low binding affinity and repeatable differential binding to ovarian tumors in mice. Here, CACNA1A is linked to ovarian cancer.